Back
PepGen Vs. Catalyst Pharmaceuticals Industry Stock Comparison
Sell
30
PEPG
PepGen
Last Price:
9.29
Seasonality Move:
23.26%
Sell
42
CPRX
Catalyst Pharmaceuticals
Last Price:
21.34
Seasonality Move:
-9.09%
Sell
30
PepGen (PEPG)
is a Sell
Is PepGen a Buy, Sell or Hold?
- The current PepGen [PEPG] share price is $9.26. The Score for PEPG is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- PEPG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $20.43. The Score for CPRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PEPG Stock Price Chart
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $20.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
PEPG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 43.03 | Sell |
| Chaikin Money Flow: | -7882 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.89 - 9.67) | Sell |
| Bollinger Bands (100): | (10.1 - 17.1) | Sell |
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 62.11 | Buy |
| Chaikin Money Flow: | -81182 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.68 - 20.5) | Buy |
| Bollinger Bands (100): | (15.2 - 19.06) | Buy |
PEPG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.09 | Buy |
| 20-day SMA: | 9.28 | Sell |
| 50-day SMA: | 11.69 | Sell |
| 200-day SMA: | 12.22 | Sell |
| 8-day EMA: | 9.16 | Buy |
| 20-day EMA: | 9.43 | Sell |
| 50-day EMA: | 11.02 | Sell |
| 200-day EMA: | 11.96 | Sell |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.04 | Buy |
| 20-day SMA: | 20.13 | Buy |
| 50-day SMA: | 18.62 | Buy |
| 200-day SMA: | 16.12 | Buy |
| 8-day EMA: | 20.19 | Buy |
| 20-day EMA: | 19.88 | Buy |
| 50-day EMA: | 18.82 | Buy |
| 200-day EMA: | 16.5 | Buy |
PepGen Earnings Growth & PEPG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and an increase next year of $0.58 per share.
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
PepGen Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Catalyst Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||